Youmei Peng

782 total citations
29 papers, 525 citations indexed

About

Youmei Peng is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Youmei Peng has authored 29 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Youmei Peng's work include HIV/AIDS drug development and treatment (11 papers), Hepatitis B Virus Studies (9 papers) and HIV Research and Treatment (6 papers). Youmei Peng is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), Hepatitis B Virus Studies (9 papers) and HIV Research and Treatment (6 papers). Youmei Peng collaborates with scholars based in China and United States. Youmei Peng's co-authors include Junbiao Chang, Qingduan Wang, Wenquan Yu, Yubing Zhou, Jianbo Li, Jinhua Jiang, Yang Yang, Qinghua Yang, Jingmin Zhang and Wei Zhang and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Youmei Peng

29 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youmei Peng China 13 169 133 65 63 59 29 525
Renbin Huang China 13 146 0.9× 175 1.3× 35 0.5× 41 0.7× 5 0.1× 32 590
Zeqi Huang China 13 362 2.1× 28 0.2× 19 0.3× 24 0.4× 22 0.4× 36 804
Yongwei Wang China 15 247 1.5× 19 0.1× 22 0.3× 84 1.3× 18 0.3× 25 589
Sandro Satta United States 12 265 1.6× 100 0.8× 62 1.0× 50 0.8× 2 0.0× 25 679
Renée Aspiotis Canada 10 371 2.2× 28 0.2× 152 2.3× 166 2.6× 5 0.1× 14 808
Li Xiao United States 18 396 2.3× 162 1.2× 68 1.0× 75 1.2× 11 0.2× 28 761
Amy Q. Wang United States 17 390 2.3× 98 0.7× 110 1.7× 148 2.3× 7 0.1× 31 1.1k
Inés Maestro Spain 10 234 1.4× 200 1.5× 82 1.3× 137 2.2× 4 0.1× 11 613
A. Benakis Switzerland 13 219 1.3× 69 0.5× 56 0.9× 67 1.1× 4 0.1× 57 789
Dimitri Schlemmer France 17 839 5.0× 123 0.9× 19 0.3× 60 1.0× 7 0.1× 25 1.1k

Countries citing papers authored by Youmei Peng

Since Specialization
Citations

This map shows the geographic impact of Youmei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youmei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youmei Peng more than expected).

Fields of papers citing papers by Youmei Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youmei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youmei Peng. The network helps show where Youmei Peng may publish in the future.

Co-authorship network of co-authors of Youmei Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Youmei Peng. A scholar is included among the top collaborators of Youmei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youmei Peng. Youmei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jinjin, et al.. (2024). A graph self-supervised residual learning framework for domain identification and data integration of spatial transcriptomics. Communications Biology. 7(1). 1123–1123. 1 indexed citations
2.
Meng, Yonggang, Bin Yu, He Huang, et al.. (2021). Discovery of Dosimertinib, a Highly Potent, Selective, and Orally Efficacious Deuterated EGFR Targeting Clinical Candidate for the Treatment of Non-Small-Cell Lung Cancer. Journal of Medicinal Chemistry. 64(2). 925–937. 46 indexed citations
3.
Xiang, Jing, Shuai Niu, Yi Liang, et al.. (2021). FNC inhibits non-small cell lung cancer by activating the mitochondrial apoptosis pathway. Genes & Genomics. 44(1). 123–131. 4 indexed citations
4.
Wang, Yafeng, Youmei Peng, Qing Li, et al.. (2021). In vitro and in vivo antiviral activity of a fluoronucleoside analog, NCC, against Coxsackie virus B3. Acta Virologica. 65(1). 58–67. 3 indexed citations
5.
Zhao, Junwei, Tianci Jiang, Pengfei Li, et al.. (2021). Tissue factor promotes airway pathological features through epithelial-mesenchymal transition of bronchial epithelial cells in mice with house dust mite-induced asthma. International Immunopharmacology. 97. 107690–107690. 9 indexed citations
6.
Jiang, Tianci, Lingling Dai, Pengfei Li, et al.. (2020). Lipid metabolism and identification of biomarkers in asthma by lipidomic analysis. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(2). 158853–158853. 48 indexed citations
7.
Peng, Youmei, Bin Huang, Wei Zhang, et al.. (2019). Gingival crevicular fluid levels of SLIT3 are increased in periodontal disease. Oral Diseases. 26(1). 182–192. 6 indexed citations
8.
Yang, Wu, Youmei Peng, Jingwen Wang, et al.. (2019). Design, synthesis, and biological evaluation of novel 2′-deoxy-2′-fluoro-2′-C-methyl 8-azanebularine derivatives as potent anti-HBV agents. Bioorganic & Medicinal Chemistry Letters. 29(11). 1291–1297. 3 indexed citations
9.
Zhang, Jingmin, Yafeng Wang, Youmei Peng, et al.. (2018). Novel fluoronucleoside analog NCC inhibits lamivudine-resistant hepatitis B virus in a hepatocyte model. The Brazilian Journal of Infectious Diseases. 22(6). 477–486. 2 indexed citations
10.
Li, Jianbo, et al.. (2018). Mechanisms of poor oral bioavailability of flavonoid Morin in rats: From physicochemical to biopharmaceutical evaluations. European Journal of Pharmaceutical Sciences. 128. 290–298. 50 indexed citations
11.
Wang, Ya-Feng, Yan Zhang, Youmei Peng, et al.. (2017). Cepharanthine hydrochloride reverses P-glycoprotein-mediated multidrug resistance in human ovarian carcinoma A2780/Taxol cells by inhibiting the PI3K/Akt signaling pathway. Oncology Reports. 38(4). 2558–2564. 21 indexed citations
12.
13.
Liu, Yuan, Youmei Peng, Jingjing Lu, et al.. (2017). Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2′-deoxy-2′-fluoro- 4′-azido nucleoside derivatives as potent anti-HBV agents. European Journal of Medicinal Chemistry. 143. 137–149. 17 indexed citations
14.
Li, Ertong, Yafeng Wang, Wenquan Yu, et al.. (2017). Synthesis and biological evaluation of a novel β-D-2′-deoxy-2′-α-fluoro-2′-β-C-(fluoromethyl)uridine phosphoramidate prodrug for the treatment of hepatitis C virus infection. European Journal of Medicinal Chemistry. 143. 107–113. 7 indexed citations
15.
Zhang, Yan, Ning Wang, Fang Ma, et al.. (2017). FNC efficiently inhibits mantle cell lymphoma growth. PLoS ONE. 12(3). e0174112–e0174112. 11 indexed citations
16.
Yang, Qinghua, Liyun Zheng, Xuejun Wang, et al.. (2015). Synthesis and Biological Evaluation of 4-Substituted Fluoronucleoside Analogs for the Treatment of Hepatitis B Virus Infection. Journal of Medicinal Chemistry. 58(9). 3693–3703. 24 indexed citations
17.
Lv, Zhigang, Wu He, Xianhai Tian, et al.. (2015). Design, synthesis, and biological evaluation of new N 4 -Substituted 2′-deoxy-2′-fluoro-4′-azido cytidine derivatives as potent anti-HBV agents. European Journal of Medicinal Chemistry. 101. 103–110. 19 indexed citations
18.
19.
Qian, Xiaolan, Wei Zhang, Yubing Zhou, et al.. (2014). Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice. European Journal of Pharmacology. 746. 206–212. 77 indexed citations
20.
Peng, Youmei, Ning Wang, Ya-Feng Wang, et al.. (2012). [Correlation between reversing effect of cepharanthine hydrochloride on multidrug resistance and P-glycoprotein expression and function of K562/ADR cells].. PubMed. 47(5). 594–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renbin Huang Breakdown of academic impact, for papers by Zeqi Huang Breakdown of academic impact, for papers by Yongwei Wang Breakdown of academic impact, for papers by Sandro Satta Breakdown of academic impact, for papers by Renée Aspiotis Breakdown of academic impact, for papers by Li Xiao Breakdown of academic impact, for papers by Amy Q. Wang Breakdown of academic impact, for papers by Inés Maestro Breakdown of academic impact, for papers by A. Benakis Breakdown of academic impact, for papers by Dimitri Schlemmer
Rankless by CCL
2026